Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Singh M, Mehendale S, Guleria R, Sarin R, Tripathy S, Gangakhedkar RR, Katoch K, Pandey RM, Panda S, Pati S, Mohapatra PR, Joshi S, Narasimhaiah S, Kodan P, Bhaskar S, Rani R, Khan AM, Swaminathan S; PreVenTB Trial Team. Singh M, et al. Among authors: kodan p. BMJ Open. 2024 Aug 31;14(8):e082916. doi: 10.1136/bmjopen-2023-082916. BMJ Open. 2024. PMID: 39645271 Free article. Clinical Trial.
Clinical characteristics, course and outcome of critically ill COVID-19 patients with previous or current TB admitted in ICU of a tertiary care COVID centre of Indian subcontinent.
Patel N, Kaur M, Aggarwal R, Ganesh V, Ayub A, Kumar R, Kodan P, Singh Y, Soni KD, Trikha A. Patel N, et al. Among authors: kodan p. Lung India. 2023 Jan-Feb;40(1):91-93. doi: 10.4103/lungindia.lungindia_249_22. Lung India. 2023. PMID: 36695269 Free PMC article. No abstract available.
Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study.
Keri VC, Arunan B, Kodan P, Soneja M, Nischal N, Varadarajan A, Didwania A, R L B, Aggarwal A, Jorwal P, Kumar A, Ray A, Sethi P, Meena VP, Khanna P, Singh AK, Aggarwal R, Soni KD, Goyal A, Das A, Trikha A, Wig N. Keri VC, et al. Among authors: kodan p. Ther Adv Vaccines Immunother. 2022 Aug 9;10:25151355221115009. doi: 10.1177/25151355221115009. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35966176 Free PMC article.
Risk factors for Coronavirus disease-associated mucormycosis.
Arora U, Priyadarshi M, Katiyar V, Soneja M, Garg P, Gupta I, Bharadiya V, Berry P, Ghosh T, Patel L, Sarda R, Garg S, Agarwal S, Arora V, Ramprasad A, Kumar A, Garg RK, Kodan P, Nischal N, Singh G, Jorwal P, Kumar A, Baitha U, Meena VP, Ray A, Sethi P, Xess I, Vikram N, Sinha S, Biswas A, Thakar A, Bhatnagar S, Trikha A, Wig N. Arora U, et al. Among authors: kodan p. J Infect. 2022 Mar;84(3):383-390. doi: 10.1016/j.jinf.2021.12.039. Epub 2021 Dec 30. J Infect. 2022. PMID: 34974056 Free PMC article.
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.
Desai D, Khan AR, Soneja M, Mittal A, Naik S, Kodan P, Mandal A, Maher GT, Kumar R, Agarwal A, Gowda NR, H V, Kumar P, Pandey S, Pandey RM, Kumar A, Ray A, Jorwal P, Nischal N, Choudhary A, Brijwal M, Madan K, Lodha R, Sinha S, Dar L, Wig N, Guleria R. Desai D, et al. Among authors: kodan p. Lancet Infect Dis. 2022 Mar;22(3):349-356. doi: 10.1016/S1473-3099(21)00674-5. Epub 2021 Nov 23. Lancet Infect Dis. 2022. PMID: 34826383 Free PMC article. Clinical Trial.
48 results